Domain	0	6	B-Protein_domain_or_region
5	7	8	I-Protein_domain_or_region
of	9	11	O
cleaved	12	19	O
high	20	24	B-Gene_or_gene_product
molecular	25	34	I-Gene_or_gene_product
weight	35	41	I-Gene_or_gene_product
kininogen	42	51	I-Gene_or_gene_product
inhibits	52	60	O
endothelial	61	72	B-Cell
cell	73	77	I-Cell
migration	78	87	O
through	88	95	O
Akt	96	99	B-Gene_or_gene_product
.	99	100	O

Domain	102	108	B-Protein_domain_or_region
5	109	110	I-Protein_domain_or_region
(	111	112	O
D5	112	114	B-Protein_domain_or_region
)	114	115	O
of	116	118	O
cleaved	119	126	O
high	127	131	B-Gene_or_gene_product
molecular	132	141	I-Gene_or_gene_product
weight	142	148	I-Gene_or_gene_product
kininogen	149	158	I-Gene_or_gene_product
(	159	160	O
HKa	160	163	B-Gene_or_gene_product
)	163	164	O
inhibits	165	173	O
angiogenesis	174	186	O
in	187	189	O
vivo	190	194	O
and	195	198	O
endothelial	199	210	B-Cell
cell	211	215	I-Cell
migration	216	225	O
in	226	228	O
vitro	229	234	O
,	234	235	O
but	236	239	O
the	240	243	O
cell	244	248	B-Cell
signaling	249	258	O
pathways	259	267	O
involved	268	276	O
in	277	279	O
HKa	280	283	B-Gene_or_gene_product
and	284	287	O
D5	288	290	B-Protein_domain_or_region
inhibition	291	301	O
of	302	304	O
endothelial	305	316	B-Cell
cell	317	321	I-Cell
migration	322	331	O
are	332	335	O
incompletely	336	348	O
delineated	349	359	O
.	359	360	O

This	361	365	O
study	366	371	O
examines	372	380	O
the	381	384	O
mechanism	385	394	O
of	395	397	O
HKa	398	401	B-Gene_or_gene_product
and	402	405	O
D5	406	408	B-Protein_domain_or_region
inhibition	409	419	O
of	420	422	O
two	423	426	O
potent	427	433	O
stimulators	434	445	O
of	446	448	O
endothelial	449	460	B-Cell
cell	461	465	I-Cell
migration	466	475	O
,	475	476	O
sphingosine	477	488	B-Gene_or_gene_product
1	489	490	I-Gene_or_gene_product
-	490	491	I-Gene_or_gene_product
phosphate	491	500	I-Gene_or_gene_product
(	501	502	O
S1P	502	505	B-Gene_or_gene_product
)	505	506	O
and	507	510	O
vascular	511	519	B-Gene_or_gene_product
endothelial	520	531	I-Gene_or_gene_product
growth	532	538	I-Gene_or_gene_product
factor	539	545	I-Gene_or_gene_product
(	546	547	O
VEGF	547	551	B-Gene_or_gene_product
)	551	552	O
,	552	553	O
that	554	558	O
act	559	562	O
through	563	570	O
the	571	574	O
P13	575	578	B-Gene_or_gene_product
-	578	579	I-Gene_or_gene_product
kinase	579	585	I-Gene_or_gene_product
-	585	586	O
Akt	586	589	B-Gene_or_gene_product
signaling	590	599	O
pathway	600	607	O
.	607	608	O

HKa	609	612	B-Gene_or_gene_product
and	613	616	O
D5	617	619	B-Protein_domain_or_region
inhibit	620	627	O
bovine	628	634	B-Organism
pulmonary	635	644	B-Cell
artery	645	651	I-Cell
endothelial	652	663	I-Cell
cell	664	668	I-Cell
(	669	670	O
BPAE	670	674	B-Cell
)	674	675	O
or	676	678	O
human	679	684	B-Organism
umbilical	685	694	B-Cell
vein	695	699	I-Cell
endothelial	700	711	I-Cell
cell	712	716	I-Cell
chemotaxis	717	727	O
in	728	730	O
the	731	734	O
modified	735	743	O
-	743	744	O
Boyden	744	750	O
chamber	751	758	O
in	759	761	O
response	762	770	O
toVEGF	771	777	B-Gene_or_gene_product
or	778	780	O
S1P	781	784	B-Gene_or_gene_product
.	784	785	O

The	786	789	O
inhibition	790	800	O
of	801	803	O
migration	804	813	O
by	814	816	O
HKa	817	820	B-Gene_or_gene_product
is	821	823	O
reversed	824	832	O
by	833	835	O
antibodies	836	846	O
to	847	849	O
urokinase	850	859	B-Gene_or_gene_product
-	859	860	I-Gene_or_gene_product
type	860	864	I-Gene_or_gene_product
plasminogen	865	876	I-Gene_or_gene_product
activator	877	886	I-Gene_or_gene_product
receptor	887	895	I-Gene_or_gene_product
.	895	896	O

Both	897	901	O
HKa	902	905	B-Gene_or_gene_product
and	906	909	O
D5	910	912	B-Protein_domain_or_region
decrease	913	921	O
the	922	925	O
speed	926	931	O
of	932	934	O
BPAE	935	939	B-Cell
cell	940	944	I-Cell
migration	945	954	O
and	955	958	O
alter	959	964	O
the	965	968	O
morphology	969	979	O
in	980	982	O
live	983	987	O
,	987	988	O
time	989	993	O
-	993	994	O
lapse	994	999	O
microscopy	1000	1010	O
after	1011	1016	O
stimulation	1017	1028	O
with	1029	1033	O
S1P	1034	1037	B-Gene_or_gene_product
or	1038	1040	O
VEGF	1041	1045	B-Gene_or_gene_product
.	1045	1046	O

HKa	1047	1050	B-Gene_or_gene_product
and	1051	1054	O
D5	1055	1057	B-Protein_domain_or_region
reduce	1058	1064	O
the	1065	1068	O
localization	1069	1081	O
of	1082	1084	O
paxillin	1085	1093	B-Gene_or_gene_product
to	1094	1096	O
the	1097	1100	O
focal	1101	1106	B-Cellular_component
adhesions	1107	1116	I-Cellular_component
after	1117	1122	O
S1P	1123	1126	B-Gene_or_gene_product
and	1127	1130	O
VEGF	1131	1135	B-Gene_or_gene_product
stimulation	1136	1147	O
.	1147	1148	O

To	1149	1151	O
better	1152	1158	O
understand	1159	1169	O
the	1170	1173	O
intracellular	1174	1187	O
signaling	1188	1197	O
pathways	1198	1206	O
,	1206	1207	O
we	1208	1210	O
examined	1211	1219	O
the	1220	1223	O
effect	1224	1230	O
of	1231	1233	O
HKa	1234	1237	B-Gene_or_gene_product
on	1238	1240	O
the	1241	1244	O
phosphorylation	1245	1260	O
of	1261	1263	O
Akt	1264	1267	B-Gene_or_gene_product
and	1268	1271	O
its	1272	1275	O
downstream	1276	1286	O
effector	1287	1295	O
,	1295	1296	O
GSK	1297	1300	B-Gene_or_gene_product
-	1300	1301	I-Gene_or_gene_product
3alpha	1301	1307	I-Gene_or_gene_product
HKa	1308	1311	B-Gene_or_gene_product
and	1312	1315	O
D5	1316	1318	B-Protein_domain_or_region
inhibit	1319	1326	O
phosphorylation	1327	1342	O
of	1343	1345	O
Akt	1346	1349	B-Gene_or_gene_product
and	1350	1353	O
GSK	1354	1357	B-Gene_or_gene_product
-	1357	1358	I-Gene_or_gene_product
3alpha	1358	1364	I-Gene_or_gene_product
after	1365	1370	O
stimulation	1371	1382	O
withVEGF	1383	1391	B-Gene_or_gene_product
and	1392	1395	O
S1P	1396	1399	B-Gene_or_gene_product
.	1399	1400	O

Inhibitors	1401	1411	O
of	1412	1414	O
Akt	1415	1418	B-Gene_or_gene_product
and	1419	1422	O
P13	1423	1426	B-Gene_or_gene_product
-	1426	1427	I-Gene_or_gene_product
kinase	1427	1433	I-Gene_or_gene_product
,	1433	1434	O
the	1435	1438	O
upstream	1439	1447	O
activator	1448	1457	O
of	1458	1460	O
Akt	1461	1464	B-Gene_or_gene_product
,	1464	1465	O
block	1466	1471	O
endothelial	1472	1483	B-Cell
cell	1484	1488	I-Cell
migration	1489	1498	O
and	1499	1502	O
disrupt	1503	1510	O
paxillin	1511	1519	B-Gene_or_gene_product
localization	1520	1532	O
to	1533	1535	O
the	1536	1539	O
focal	1540	1545	B-Cellular_component
adhesions	1546	1555	I-Cellular_component
after	1556	1561	O
stimulation	1562	1573	O
with	1574	1578	O
VEGF	1579	1583	B-Gene_or_gene_product
and	1584	1587	O
S1P	1588	1591	B-Gene_or_gene_product
.	1591	1592	O

Therefore	1593	1602	O
we	1603	1605	O
suggest	1606	1613	O
that	1614	1618	O
HKa	1619	1622	B-Gene_or_gene_product
through	1623	1630	O
its	1631	1634	O
D5	1635	1637	B-Protein_domain_or_region
domain	1638	1644	O
alters	1645	1651	O
P13	1652	1655	B-Gene_or_gene_product
-	1655	1656	I-Gene_or_gene_product
kinase	1656	1662	I-Gene_or_gene_product
-	1662	1663	O
Akt	1663	1666	B-Gene_or_gene_product
signaling	1667	1676	O
to	1677	1679	O
inhibit	1680	1687	O
endothelial	1688	1699	B-Cell
cell	1700	1704	I-Cell
migration	1705	1714	O
through	1715	1722	O
alterations	1723	1734	O
in	1735	1737	O
the	1738	1741	O
focal	1742	1747	B-Cellular_component
adhesions	1748	1757	I-Cellular_component
.	1757	1758	O

